Here we go again, another wild claim. You don't need a team? Are you actually aware of the costs of cell-culturing? This has to be done in a special laboratory. According to Mr.Hall from Replicel (and their technology is pretty much the same) the costs will be about the same, or at least competitive. And he wasn't even sure about that.
Aderans
Collapse
X
-
Comment
-
Here we go again, another wild claim. You don't need a team? Are you actually aware of the costs of cell-culturing? This has to be done in a special laboratory. According to Mr.Hall from Replicel (and their technology is pretty much the same) the costs will be about the same, or at least competitive. And he wasn't even sure about that.Comment
-
I really think Aderans and Tokyo should join their research. That would be a no fail strategy.
We learned from replicel that doing what they claim is not easy at all and bound to fail most of the time.
Comment
-
Replicel did not fail, but I don't want to go through this the 10th time. I heard a German interview with Prof.Hoffmann today and some patiens were showing >18% regrowth. That is absoluteley enough for Phase I. Phase II is planned to start 2013 in Germany with 60-100 participants and he is very confident about it.Comment
-
Replicel did not fail, but I don't want to go through this the 10th time. I heard a German interview with Prof.Hoffmann today and some patiens were showing >18% regrowth. That is absoluteley enough for Phase I. Phase II is planned to start 2013 in Germany with 60-100 participants and he is very confident about it.Comment
-
.
Comment
-
Nobody knows what will happen.Comment
-
i sent an email to histogen 1 month ago, but everytime i ask for the timeline they just ignore that question and answer the rest. at least they answer. here is the answer after asking them for updates:
Thank you for your interest and message. In addition to information from Dr. Ziering’s clinical study, the HSC page of our website has been updated with preliminary results from the ongoing Phase I/II clinical trial (http://www.histogen.com/applications/hsc.htm).
Histogen is pleased with the progress of the HSC program, and the safety and efficacy results seen with the treatment thus far. Further clinical trials will be required prior to market introduction of HSC in the US or elsewhere.
Thank you,
Eileen
Eileen Brandt
Director of Corporate Communications
Histogen, Inc
and here is an answer from aderans 3 months ago when i asked them for updates:
Right now our clinical sites have completed their enrollment for theactive protocols. We anticipate starting additional protocols and clinicsites in the coming months. Please continue to keep an eye on ourwebsite for updates using the link below. http://aderansresearch.com/ari_clinicupdates.html Thank you for your interest.
Info Desk
Aderans ResearchComment
-
Comment
-
Statistically speaking and at this point, I don't even consider Replicel as part of the game. I have my scope narrowed down to Histogen and Aderans, particularly the latter of the two. The technology Aderans is touting is a bit like a HT on steroids, but it can ultimately cure baldness. When you think of a normal single session transplant of typically around 2-4k grafts (not FUE), Aderans looks awesome. You're talking about unlimited follicles compared to a couple of thousand here and there.
I do hope that hair loss technology continues to progress until an actual pill can stop hair loss. Until that point, I'm fine with a small incision in the back of my scalp to produce unlimited follicles. I just want my damn hair line back lol.Comment
-
Comment
Comment